Profund Advisors LLC Trims Stock Holdings in Maximus, Inc. (NYSE:MMS)

Profund Advisors LLC decreased its holdings in Maximus, Inc. (NYSE:MMS) by 15.0% in the 1st quarter, Holdings Channel.com reports. The firm owned 3,358 shares of the health services provider’s stock after selling 594 shares during the period. Profund Advisors LLC’s holdings in Maximus were worth $264,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently modified their holdings of MMS. Quadrant Capital Group LLC grew its stake in Maximus by 119.8% during the fourth quarter. Quadrant Capital Group LLC now owns 389 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 212 shares in the last quarter. Fifth Third Bancorp grew its stake in Maximus by 26.0% during the first quarter. Fifth Third Bancorp now owns 728 shares of the health services provider’s stock valued at $57,000 after acquiring an additional 150 shares in the last quarter. Harvest Fund Management Co. Ltd purchased a new position in Maximus during the first quarter valued at approximately $62,000. Captrust Financial Advisors grew its stake in Maximus by 14.9% during the second quarter. Captrust Financial Advisors now owns 1,303 shares of the health services provider’s stock valued at $81,000 after acquiring an additional 169 shares in the last quarter. Finally, Ronald Blue Trust Inc. grew its stake in Maximus by 11.0% during the first quarter. Ronald Blue Trust Inc. now owns 1,296 shares of the health services provider’s stock valued at $95,000 after acquiring an additional 128 shares in the last quarter. Hedge funds and other institutional investors own 99.30% of the company’s stock.

Maximus Trading Down 0.8 %

Shares of MMS opened at $78.96 on Friday. The firm has a market cap of $4.80 billion, a price-to-earnings ratio of 28.20 and a beta of 0.70. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.46 and a current ratio of 1.46. Maximus, Inc. has a fifty-two week low of $54.46 and a fifty-two week high of $89.69. The firm has a 50 day moving average price of $82.76 and a 200-day moving average price of $81.68.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Wednesday, August 2nd. The health services provider reported $0.78 earnings per share for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.36). The business had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.20 billion. Maximus had a return on equity of 15.11% and a net margin of 3.56%. The company’s revenue was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.78 earnings per share. As a group, equities research analysts forecast that Maximus, Inc. will post 3.88 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 31st. Investors of record on Tuesday, August 15th were issued a dividend of $0.28 per share. The ex-dividend date was Monday, August 14th. This represents a $1.12 dividend on an annualized basis and a yield of 1.42%. Maximus’s dividend payout ratio is currently 40.00%.

Wall Street Analyst Weigh In

A number of research firms have commented on MMS. Stifel Nicolaus began coverage on shares of Maximus in a research note on Friday, August 18th. They issued a “buy” rating and a $102.00 price target for the company. TheStreet cut shares of Maximus from a “b” rating to a “c+” rating in a research note on Tuesday, August 15th. Finally, StockNews.com began coverage on shares of Maximus in a research note on Thursday, August 17th. They issued a “hold” rating for the company.

Insider Activity at Maximus

In related news, Director Michael J. Warren sold 2,490 shares of the company’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $79.53, for a total transaction of $198,029.70. Following the completion of the sale, the director now directly owns 3,890 shares in the company, valued at approximately $309,371.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, Director Michael J. Warren sold 2,490 shares of the company’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $79.53, for a total transaction of $198,029.70. Following the completion of the sale, the director now directly owns 3,890 shares in the company, valued at approximately $309,371.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Bruce Caswell purchased 3,141 shares of the stock in a transaction that occurred on Friday, August 4th. The shares were purchased at an average price of $79.07 per share, with a total value of $248,358.87. Following the completion of the acquisition, the chief executive officer now directly owns 210,484 shares in the company, valued at $16,642,969.88. The disclosure for this purchase can be found here. 1.30% of the stock is currently owned by company insiders.

Maximus Profile

Maximus, Inc provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.